Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response.

Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated...

Full description

Bibliographic Details
Main Authors: Scott A Read, Enoch S Tay, Mahsa Shahidi, Kate S O'Connor, David R Booth, Jacob George, Mark W Douglas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4551482?pdf=render